Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma

Fig. 3

High PHGDH expression is correlated with clinicopathologic features in patients with endometrial carcinoma. (A) Differences in PHGDH expression in TCGA-UCEC tissues and adjacent normal tissues. (B) Differences in PHGDH expression in normal samples from the GTEx and TCGA-UCEC samples. (C) Differences in PHGDH expression in TCGA-UCEC samples and paired adjacent samples. (D, E) ROC curve for Fig. 3A,B. (F) PHGDH protein levels were markedly upregulated in tumor tissues compared with that in non-paired normal tissues. (G) Representative immunohistochemistry images of PHGDH expression in endometrial carcinoma tissues and their normal controls

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us